Stocktoria
CONSTELLIUM SE CSTM
CONSTELLIUM SE financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $8.4B | $7.3B | $7.8B |
| R&D expense | $51.0M | $49.0M | $52.0M |
| SG&A expense | $332.0M | $313.0M | $317.0M |
| Income tax | $133.0M | $75.0M | $75.0M |
| Net income | $273.0M | $56.0M | $152.0M |
| EPS (diluted) | $1.92 | $0.38 | $1.03 |
| Operating cash flow | $489.0M | $301.0M | $432.0M |
| Free cash flow | $159.0M | -$112.0M | $66.0M |
| Cash & equivalents | $120.0M | $141.0M | $223.0M |
| Inventory | $1.4B | $1.2B | $1.2B |
| Total assets | $5.4B | $4.7B | $4.9B |
| Total liabilities | $4.4B | $4.0B | $4.2B |
| Shareholders' equity | $971.0M | $727.0M | $742.0M |
Growth · year-over-year · Revenue CAGR 3.9%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | +15.2% | -6.3% | — |
| Net income growth | +387.5% | -63.2% | — |
| EPS growth | +405.3% | -63.1% | — |
| Free cash flow growth | — | -269.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.